Kazuo T. Suzuki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kazuo T. Suzuki has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Yasumitsu Ogra
Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo, Chiba 260-8675, Japan
15 shared publications - Noriyuki Suzuki
Faculty of Pharmaceutical Sciences, Toho University, Funabashi, Japan
8 shared publications Masayoshi Ohmichi
Chiba City Institute of Health and Environment, Chiba 261-0001, Japan
5 shared publicationsKazuki Kurasaki
4 shared publicationsShinji Yoneda
3 shared publicationsAkio Katagiri
Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan
2 shared publications
Latest Publications
- 2 February 2008
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 21 (3) , 678-685
Identification of the Major Arsenic-Binding Protein in Rat Plasma As the Ternary Dimethylarsinous−Hemoglobin−Haptoglobin Complex
Chronic exposure to arsenic causes a wide range of diseases such as hyperkeratosis, cardiovascular diseases, and skin, lung, and bladder cancers, and millions of people are chronically exposed to arsenic worldwide. However, little is known about the mechanisms underlying these toxic actions. The metabolism of arsenic is essential for understanding the toxic actions. Here, we identified the major arsenic-binding protein (As-BP) in the plasma of rats after oral administration of arsenite by the use of two different HPLC columns, gel filtration and anion exchange ones, coupled with an inductively coupled argon plasma mass spectrometer (ICP MS). The molecular mass of the As-BP was estimated to be 90 kDa based on results using the former column, and arsenic bound to this protein only in the form of dimethylarsinous acid (DMAIII) in the plasma in vivo. In addition, the purified As-BP was shown to consist of two different proteins, haptoglobin (Hp) of 37 kDa (three bands) and the hemoglobin (Hb) α chain of 14 kDa (single band), using sodium dodecylsulfate−polyacrylamide gel electrophoresis (SDS−PAGE) and matrix-assisted laser desorption ionization−time-of-flight mass spectrometry (MALDI-TOF MS), respectively, suggesting that the As-BP was the ternary DMAIII−Hb−Hp complex. To confirm the present observations, an arsenic-binding assay was carried out in vitro. Although DMAIII bound directly to fresh rat plasma proteins, they were different from that identified in vivo. However, when a DMAIII-exposed rat RBC lysate (DMAIII binds to Hb in rat RBCs) was added to control rat plasma, a new arsenic peak increased at the expense of the arsenic-Hb one. Furthermore, this new arsenic peak was consistent with the As-BP identified in the plasma in vivo, suggesting that arsenic bound to Hb further binds to haptoglobin (Hp), forming the ternary As−Hb−Hp complex.
- 2 February 2008
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 21 (3) , 678-685
Identification of the Major Arsenic-Binding Protein in Rat Plasma As the Ternary Dimethylarsinous−Hemoglobin−Haptoglobin Complex
Chronic exposure to arsenic causes a wide range of diseases such as hyperkeratosis, cardiovascular diseases, and skin, lung, and bladder cancers, and millions of people are chronically exposed to arsenic worldwide. However, little is known about the mechanisms underlying these toxic actions. The metabolism of arsenic is essential for understanding the toxic actions. Here, we identified the major arsenic-binding protein (As-BP) in the plasma of rats after oral administration of arsenite by the use of two different HPLC columns, gel filtration and anion exchange ones, coupled with an inductively coupled argon plasma mass spectrometer (ICP MS). The molecular mass of the As-BP was estimated to be 90 kDa based on results using the former column, and arsenic bound to this protein only in the form of dimethylarsinous acid (DMAIII) in the plasma in vivo. In addition, the purified As-BP was shown to consist of two different proteins, haptoglobin (Hp) of 37 kDa (three bands) and the hemoglobin (Hb) α chain of 14 kDa (single band), using sodium dodecylsulfate−polyacrylamide gel electrophoresis (SDS−PAGE) and matrix-assisted laser desorption ionization−time-of-flight mass spectrometry (MALDI-TOF MS), respectively, suggesting that the As-BP was the ternary DMAIII−Hb−Hp complex. To confirm the present observations, an arsenic-binding assay was carried out in vitro. Although DMAIII bound directly to fresh rat plasma proteins, they were different from that identified in vivo. However, when a DMAIII-exposed rat RBC lysate (DMAIII binds to Hb in rat RBCs) was added to control rat plasma, a new arsenic peak increased at the expense of the arsenic-Hb one. Furthermore, this new arsenic peak was consistent with the As-BP identified in the plasma in vivo, suggesting that arsenic bound to Hb further binds to haptoglobin (Hp), forming the ternary As−Hb−Hp complex.
- 1 February 2008
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 227 (1) , 76-83
Preferential organ distribution of methylselenol source Se-methylselenocysteine relative to methylseleninic acid
- 1 February 2008
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 227 (1) , 76-83
Preferential organ distribution of methylselenol source Se-methylselenocysteine relative to methylseleninic acid
- 1 July 2007
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1770 (7) , 1053-1061
Selenocysteine β-lyase and methylselenol demethylase in the metabolism of Se-methylated selenocompounds into selenide
- 1 July 2007
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1770 (7) , 1053-1061
Selenocysteine β-lyase and methylselenol demethylase in the metabolism of Se-methylated selenocompounds into selenide
- 1 January 2007
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 218 (2) , 166-173
Metabolic differences between two dimethylthioarsenicals in rats
- 1 January 2007
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 218 (2) , 166-173
Metabolic differences between two dimethylthioarsenicals in rats
- 1 December 2006
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 217 (2) , 185-195
Metabolism of 76Se-methylselenocysteine compared with that of 77Se-selenomethionine and 82Se-selenite
- 1 December 2006
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 217 (2) , 185-195
Metabolism of 76Se-methylselenocysteine compared with that of 77Se-selenomethionine and 82Se-selenite
- 1 November 2006
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 217 (1) , 43-50
Simultaneous tracing of 76Se-selenite and 77Se-selenomethionine by absolute labeling and speciation
- 1 November 2006
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 217 (1) , 43-50
Simultaneous tracing of 76Se-selenite and 77Se-selenomethionine by absolute labeling and speciation
- 1 November 2006
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 217 (1) , 51-62
Availability and metabolism of 77Se-methylseleninic acid compared simultaneously with those of three related selenocompounds
- 1 November 2006
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 217 (1) , 51-62
Availability and metabolism of 77Se-methylseleninic acid compared simultaneously with those of three related selenocompounds
- 1 October 2006
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 216 (2) , 303-308
Distribution and reuse of 76Se-selenosugar in selenium-deficient rats
- 1 October 2006
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 216 (2) , 303-308
Distribution and reuse of 76Se-selenosugar in selenium-deficient rats
- 1 September 2006
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 215 (2) , 189-197
Metabolic transformation of methylseleninic acid through key selenium intermediate selenide
- 1 September 2006
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 215 (2) , 189-197
Metabolic transformation of methylseleninic acid through key selenium intermediate selenide
- 1 August 2005
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 206 (1) , 1-8
Selenosugar and trimethylselenonium among urinary Se metabolites: dose- and age-related changes
- 1 August 2005
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 206 (1) , 1-8
Selenosugar and trimethylselenonium among urinary Se metabolites: dose- and age-related changes